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Summary
Ghrelin and leptin are suggested to regulate energy homeostasis as mutual antagonists on hypothalamic neurons that
regulate feeding behavior. We employed reverse genetics to investigate the interplay between ghrelin and leptin. Leptin-
deficient mice (ob/ob) are hyperphagic, obese, and hyperglycemic. Unexpectedly, ablation of ghrelin in ob/ob mice fails
to rescue the obese hyperphagic phenotype, indicating that the ob/ob phenotype is not a consequence of ghrelin unopposed
by leptin. Remarkably, deletion of ghrelin augments insulin secretion in response to glucose challenge and increases periph-
eral insulin sensitivity; indeed, the hyperglycemia exhibited by ob/ob mice is markedly reduced when ob/ob mice are bred
onto the ghrelin2/2 background. We further demonstrate that ablation of ghrelin reduces expression of Ucp2 mRNA in
the pancreas, which contributes toward enhanced glucose-induced insulin secretion. Hence, chronically, ghrelin controls
glucose homeostasis by regulating pancreatic Ucp2 expression and insulin sensitivity.Introduction
The literature is replete with studies designed to establish the
physiological role of ghrelin. However, these investigations in-
volved pharmacological administration of ghrelin; therefore,
the results, while valid, must be interpreted with caution. For
example, each injection of exogenous ghrelin or ghrelin mimetic
instantly causes the release of growth hormone releasing
hormone, corticotrophin releasing hormone, neuropeptide Y
(NPY), agouti-related protein (AGRP), adrenocorticotrophin,
growth hormone, and glucocorticoids, as well as inhibiting the
function and release of somatostatin (Cowley et al., 2003; Smith
et al., 1997; Tschop et al., 2002; Tung et al., 2004). Plasma pro-
files of ghrelin suggest that ghrelin is normally released episod-
ically with peak concentrations approximately double those of
valleys. Ghrelin administered acutely interrupts and markedly
alters the normal episodic pattern of ghrelin secretion, which
confounds clear interpretation of the biological role of endoge-
nous ghrelin. Accordingly, we employ genetic models to eluci-
date the physiological function of ghrelin, because even with
the caveat of the possible influence of compensatory pathways,
we believe that these models are more relevant for understand-
ing ghrelin physiology.
Ghrelin and leptin act on feeding centers in the brain and reg-
ulate energy balance by counter-regulating the activity of NPY
and AGRP hypothalamic neurons (Bagnasco et al., 2002; Cow-
ley et al., 2003). Ghrelin is an octanoylated 28 amino acid orexi-
genic peptide produced mainly by the stomach (Kojima et al.,
1999), which when administered acutely, increases appetite;
however, mice lacking ghrelin have normal appetites (Sun
et al., 2003; Wortley et al., 2004). The protein leptin is produced
by adipocytes and inhibits food intake. Mice with a mutation
in the leptin gene (ob/ob) are characterized by severe obesity,
hyperglycemia, hyperinsulinemia, glucose intolerance, and hy-CELL METABOLISM 3, 379–386, MAY 2006 ª2006 ELSEVIER INC. DOpothermia (Meinders et al., 1996; Muzzin et al., 1996). To
investigate the interrelated physiological roles of ghrelin and lep-
tin, we generated ghrelin- and leptin-deficient mutant mice
(ghrelin(2/2).ob/ob).
Results
General characterization of ghrelin-deficient ob/obmice
We backcrossed ghrelin2/2mice for ten generations to C57BL/
6J mice and then bred them onto the ob/ob C57BL/6J back-
ground. We monitored body weight changes and food intake
of wild-type (WT), ghrelin2/2, ob/ob, and ghrelin(2/2).ob/ob
mice. In agreement with our previous results, there were no dif-
ferences in body weights or food intake of WT compared to
ghrelin2/2 mice. Compared to WT and ghrelin2/2 mice, body
weights in ob/ob and ghrelin(2/2).ob/ob mice were higher as
early as 2 weeks of age; marked differences were apparent at
6 weeks of age. Surprisingly, ablation of ghrelin in ob/ob mice
did not significantly reduce either body weight (Figure 1A)
or food intake (data not shown), and fat content of ob/ob and
ghrelin(2/2).ob/ob was identical (Figure 1B). We conclude that
in the leptin deficient ob/obmouse, ghrelin does not play a dom-
inant role in either appetite regulation or fat deposition.
The ob/obmice have a paucity of brown fat and impaired ca-
pacity for nonshivering thermogenesis and are unable to main-
tain body temperature under cold conditions (Arvaniti et al.,
1998). Ghrelin suppresses sympathetic nerve activity in brown
adipose tissue (Yasuda et al., 2003), suggesting that ablating
ghrelin in ob/ob mice might restore the capacity for cold-
induced thermogenesis. To determine whether ghrelin deletion
improved thermoregulation, mice were exposed to 4ºC ambient
temperature for 90 min, and core body temperature was
measured at 15 min intervals. However, like ob/ob mice, the
core body temperature of ghrelin(2/2).ob/ob mice droppedI 10.1016/j.cmet.2006.04.004 379
S H O R T A R T I C L EFigure 1. Growth curve, body composition, and thermoregulation
Experiments were performed with five littermate male mice. The results are presented as mean 6 SE.
A)Bodyweights from8–14weeksof age, p<0.001, obesemice (ob/obandghrelin(2/2).ob/ob) versus leanmice (WTandghrelin2/2); p>0.05,ob/ob vs.ghrelin(2/2).ob/ob.
B)Whole-body fat content. p < 0.001, obese mice versus lean mice; p > 0.05, ob/ob versus ghrelin(2/2).ob/ob.
C) The rectal temperature of the mice exposed to 4ºC temperature. p < 0.05 at 15 min; from 30 min on, p < 0.001, obese mice versus lean mice. The temperature drop in
ghrelin(2/2).ob/ob was similar compared to ob/ob.precipitously; by contrast, WT and ghrelin2/2 maintained core
body temperature (Figure 1C). Hence, in ob/ob mice, ablation
of ghrelin does not restore the ability to maintain body tempera-
ture in a cold environment.
Deletion of ghrelin enhances glucose-dependent insulin
release and increases insulin sensitivity
Glucose and insulin levels in ob/ob mice undergo dynamic
changes, and the mice display their most severe diabetes
at 12 weeks of age (Menahan, 1983). Ghrelin and its receptor
(growth hormone secretagogue receptor, GHS-R) are ex-
pressed in pancreatic islets (Howard et al., 1996; Prado et al.,
2004; Wierup et al., 2002, 2004). To investigate how ghrelin
might influence glucose metabolism, we monitored glucose
levels in lean mice (WT and ghrelin2/2) and obese mice (ob/ob
and ghrelin(2/2).ob/ob) at different ages. The lean mice were
euglycemic; as expected, glucose and insulin levels were ele-
vated in ob/ob and ghrelin(2/2).ob/ob mice (Figures 2A–2C).
Blood glucose was elevated at age 4 weeks in ob/ob mice
and at 6 weeks in ghrelin(2/2).ob/ob mice. Surprisingly, al-
though obesity was as severe as in ob/ob mice, ghrelin(2/2).
ob/ob exhibited lower glucose levels and their blood glucose
normalized upon fasting (Figures 2A and 2B). Hence, ablation
of ghrelin markedly improved glucose homeostasis in ob/ob
mice.
The improvement in glucose homeostasis in ghrelin(2/2).
ob/obmice was accompanied by increased serum insulin levels
(Figure 2C). C-peptide levels were measured and found to be
significantly elevated in ghrelin(2/2).ob/ob mice compared to
ob/ob mice (Figure 2D) indicating that the increase in serum in-
sulin was due to increased insulin secretion. The data suggest
that deletion of ghrelin improves pancreatic b cell function and
that changes in ghrelin concentrations modulate glucose sensi-
tivity of the b cells.
We next performed intraperitoneal glucose tolerance tests
(IP-GTT). A low-glucose dose (0.625g/kg) was selected because
ob/ob mice are glucose-intolerant. Remarkably, compared to380ob/ob mice, ghrelin(2/2).ob/ob mice displayed reduced blood
glucose concentrations 15, 30- and 60 min following glucose in-
jection (Figure 2E), whichwas accompanied by increased insulin
secretion (Figure 2F). Restoration of the first-phase of insulin se-
cretion in ob/ob mice by ghrelin ablation has clinical relevance,
because in humans the loss of first-phase insulin secretion is
predictive of the development of Type 2 diabetes (Poitout and
Robertson, 1996); therefore, in subjects at risk for Type 2 diabe-
tes, treatment with a ghrelin antagonist may prove beneficial.
To investigate further the consequences of ghrelin ablation on
insulin secretion and insulin sensitivity, we performed IP-GTT in
ghrelin2/2 mice using a higher glucose dose (2.5 g/kg). Com-
pared to WT, ghrelin2/2 mice exhibited significantly lower glu-
cose levels at 30, 60 and 120 min following glucose challenge
(Figure 3A) and correspondingly higher levels of insulin (Fig-
ure 3B). Notably, like ghrelin(2/2).ob/ob mice, the initial insulin
response at 15 min was significantly (p = 0.002) higher in the
ghrelin2/2 compared toWTmice. To investigate the acute effect
of ghrelin on glucose-induced insulin secretion, 18h fasted
ghrelin2/2 mice were subjected to IPGTT using vehicle + glu-
cose, and ghrelin + glucose. The latter treatment produced
higher blood glucose (Figure 3C) and markedly lower insulin
levels (Figure 3D), showing that ghrelin acutely suppresses insu-
lin release. These results further support our conclusion that im-
proved glucose tolerance observed in ghrelin(2/2).ob/ob mice
during IP-GTT is a consequence of ghrelin ablation, and ghrelin
ablation improves pancreatic b cell function by increasing insulin
secretion in response to a glucose challenge.
Improved glucose tolerance would also be facilitated if ghrelin
ablation increased insulin sensitivity. To test this possibility, an
insulin tolerance test (ITT) was performed. A greater reduction
in glucose levels were observed 30 min following insulin dosing
in ghrelin ablated mice, suggesting increased insulin sensitivity
(Figure 3E). To more thoroughly address whether ablation of
ghrelin improved insulin sensitivity, WT and ghrelin2/2 mice
were subjected to euglycemic hyperinsulinemic clamp studies.
Glucose production rate was measured using [3-3H] glucoseCELL METABOLISM : MAY 2006
Ghrelin’s role in glucose homeostasisFigure 2. Glucose, insulin, C-peptide, and IP-GTT
The results are presented as mean 6 SE. n = 5. *p < 0.05, **p < 0.001, ob/ob versus ghrelin(2/2).ob/ob.
A) Fed blood glucose.
B and C) Fed/fasted (24 hr) blood glucose and plasma insulin. Hyperglycemia and hyperinsulinemia were present in obese mice but not in lean mice.
D) Fasted (24 hr) plasma C-peptide.
E and F) IP-GTT (0.625 g/kg): blood glucose (E) and plasma insulin (F) values were assessed. *p < 0.05, at 15, 30, and 60 min for glucose, and 15 and 60 min for insulin.infusion to allow estimation of whole body glucose disposal
(Saha et al., 2004). Basal hepatic glucose production rate was
the same in both genotypes (Figure 3F). However, during the
low-dose insulin clamp, suppression of glucose productionCELL METABOLISM : MAY 2006was higher in ghrelin2/2 mice (Figure 3F, p < 0.05), suggesting
that the liver of ghrelin2/2 mice was more sensitive to insulin.
Furthermore, a 33% increase (p = 0.025) in glucose infusion
rate (GIR) and a 20% increase (p = 0.036) in glucose disposal381
S H O R T A R T I C L EFigure 3. IP-GTT, ITT, and low-dose hyperinsulinemic-euglycemic clamp in ghrelin2/2 mice
The results are presented as mean 6 SE. n = 6–10. *p < 0.05, **p < 0.001. p value was evaluated between WT and ghrelin2/2 in (A, B, and E–H).
A and B) IP-GTT (glucose 2.5 g/kg): 8-week-old conscious male mice were used. Glucose (A) and plasma insulin (B) values were assessed.
Cand D) The effect of exogenous ghrelin on glucose-induced insulin secretion in ghrelin2/2mice. 2.5 g/kg glucose with or without 150 nmol/kg ghrelin were ip injected into
18 hr fasted ghrelin2/2 mice, *p < 0.05, **p < 0.001 saline versus ghrelin treatment. Glucose (C) and insulin (D) responses were evaluated.
E) ITT (insulin 0.75 U/kg): Glucose responses of 8-week-old conscious male mice. Glucose responses: *p < 0.05 at time 30 min only.
F, G, and H)Hyperinsulinemic-euglycemic clamp studies: (F) glucose production rate (GPR) at basal and low-dose insulin clamp conditions; (G) glucose infusion rate (GIR);
(H) glucose disposal rate (GDR).rate (GDR) were detected (Figures 3G and 3H), indicating that
besides augmenting glucose-induced insulin secretion, ghrelin
ablation increased peripheral insulin sensitivity. By inference,
ghrelin apparently modulates glucose homeostasis by regulat-
ing glucose-stimulated insulin secretion and insulin sensitivity.382Mechanism of ghrelin regulation of insulin secretion
Low plasma levels of leptin and high plasma levels of resistin
are associated with obesity, insulin resistance and diabetes
(Banerjee et al., 2004). To determine whether leptin or resistin
explained the metabolic adaptation associated with ablation ofCELL METABOLISM : MAY 2006
Ghrelin’s role in glucose homeostasisFigure 4. Plasma leptin and resistin levels and Ucp2 mRNA expression
The results are presented as mean 6 SE. n = 3-6.
A and B) Leptin (A) and resistin (B) plasma concentrations were measured in 8-month-old male mice after 24 hr fasting. * p < 0.05, WT versus ghrelin2/2.
CandD) Taqman relative quantification ofUcp2mRNA expression in whole pancreas (C) and pancreatic islets (D) wasmeasured in 5-month-oldmalemice. (C) The level of
expression in WT was defined as 1, the rest of samples were expressed as relative fold of expression compared to WT. *p < 0.05, WT versus ghrelin2/2, ob/ob versus
ghrelin(2/2).ob/ob. The results in (D) are normalized to WT data in (C). *p< 0.05, WT islets versus ghrelin-/- islets.
E) UCP2 mRNA expression in liver, lung, and WAT of 8-week-old male littermate mice. *p < 0.05, WT versus ghrelin2/2 for pancreas, lung, and WAT; p = 0.058 for liver.ghrelin, plasma leptin and resistin were measured. Consistent
with our previous findings, leptin levels were not significantly dif-
ferent in WT and ghrelin2/2 mice (Sun et al., 2003; Figure 4A).
Resistin levels were higher in obese than in lean mice and lower
in ghrelin2/2 than inWTmice. However, resistin levels were sim-
ilar in ob/ob and ghrelin(2/2).ob/obmice (Figure 4B); therefore,
resistin does not play a role in the improved glucose homeosta-
sis associated with ghrelin ablation.
Mitochondrial uncoupling protein-2 (UCP2) regulates ATP
production. In the pancreas, an increase in the ATP/ADP ratio
depolarizes the membrane of pancreatic b cells causing Ca2+
influx and insulin release. Accordingly, we measured Ucp2
mRNA in the pancreas of WT, ghrelin2/2, ob/ob, and
ghrelin(2/2).ob/ob mice by real time RT-PCR. Obese mice
had the highest levels of Ucp2 expression, which was likely
due to increased b cell mass resulting from leptin inactivation
(Bock et al., 2003). Strikingly, ablation of ghrelin in both obese
and lean mice reduces pancreatic Ucp2 mRNA expression
(Figure 4C). The same magnitude of attenuation was evident in
pancreatic islets, where the concentration of Ucp2 mRNA was
30-fold higher than in pancreas (Figure 4D). Therefore, chronic
deprivation of ghrelin increases glucose sensitivity of pancreatic
b cells by reducing Ucp2 expression. Ucp2 expression is alsoCELL METABOLISM : MAY 2006reduced in the liver (p = 0.058) and lung (p < 0.05) of ghrelin2/2
mice (Figure 4E), but increased in WAT (p < 0.05). In skeletal
muscle, Ucp2 mRNA was barely detectable in both WT and
ghrelin2/2mice (data not shown). This relative tissue distribution
and expression levels in WT mice are consistent with those de-
scribed previously (Fleury and Sanchis, 1999).
Discussion
While pharmacologically, ghrelin and leptin have opposite ef-
fects on food intake, our results show that deletion of ghrelin in
ob/ob mice does not rescue the obese phenotype (Figures 1A
and 1B). Hence, unopposed ghrelin action in leptin deficient
ob/obmice is not the underlying causeof obesity. A study in obe-
sity-prone juvenile rats also concluded that ghrelin was not a
proximate cause of obesity (Levin et al., 2003). However, we did
observe modest, but consistently higher body weight in
ghrelin(2/2).ob/obmice compared to ob/obmice, which could
be due to higher insulin levels. In brown adipose tissue, ghrelin
suppresses sympathetic nerve activity (Yasuda et al., 2003);
however, we showed that ghrelin ablation in ob/ob mice failed
to improve cold exposure-induced thermogenesis (Figure 1C),383
S H O R T A R T I C L Ewhich is likely explained by the lack of brown fat associated with
leptin deficiency.
By comparing the results of IP-GTT, ITT on WT and ob/ob
mice with those from ghrelin2/2 and ghrelin(2/2).ob/ob mice,
we showed that ghrelin ablation improves glucose tolerance
by amplifying glucose stimulated insulin secretion (Figures 2
and 3). We also showed that acute ghrelin administration to
ghrelin2/2 mice during an IP-GTT reverses the improved glu-
cose tolerance of ghrelin2/2 mice by markedly inhibiting insulin
secretion (Figures 3C and 3D). These results indicate that ghrelin
regulates b cell function. Furthermore, euglycemic hyperinsuli-
nemic clamp studies showed that ghrelin ablation increases pe-
ripheral insulin sensitivity (Figures 3F–3H).
Dezaki et al reported that acute ghrelin administration nega-
tively regulates glucose-stimulated insulin secretion in rats,
which was prevented by a ghrelin antagonist (Dezaki et al.,
2004). These investigators found that acute treatment with ghre-
lin and ghrelin receptor antagonists had no effect on insulin sen-
sitivity. However, we found using euglycemic hyperinsulinemic
clamps on mice that lacked endogenous ghrelin that ghrelin
ablation improves insulin sensitivity as well b cell function. How-
ever, because insulin release is markedly elevated by ghrelin
ablation, improved b cell function may play the dominant role
in ghrelin regulation of glucose homeostasis.
During investigations to determine why ghrelin deletion
causes increased insulin secretion in response to glucose, we
found thatUcp2 expression was lower in the pancreas of ghrelin
ablated mice. This is significant because Ucp2 regulates ATP
production and the membrane potential of b cells in pancreatic
islets is regulated by the ATP-sensitive K+ channel (KATP). Low-
ering Ucp2 increases the ATP/ADP ratio reducing opening of
KATP which depolarizes the b cell and opens L-type Ca
2+ chan-
nels, thereby increasing intracellular Ca2+ and insulin release.
Hence, increased glucose sensitivity of the b cell in ghrelin ab-
lated mice can be explained by increased depolarization of
b cells allowing increased influx of Ca2+. This explanation is con-
sistent with observations made in Ucp2 +/2 mice, which ex-
press 50% lower levels of Ucp2 mRNA than WT mice and their
response to IPGTT closely resembles that of ghrelin2/2 mice
(Zhang et al., 2001). Furthermore, Ucp2(2/2).ob/ob mice, like
ghrelin(2/2).ob/obmice, also manifest improved glucose toler-
ance. Hence, chronically, ghrelin regulates the glucose sensitiv-
ity of pancreatic b cells by modulating Ucp2 expression.
Altered Ucp2 expression is also linked to another regulator of
metabolic function, the silent information regulator 2 (Sir2) pro-
tein family (Blander and Guarente, 2004). Transgenic mice engi-
neered to overexpress Sirt1 (the mammalian version of Sir2) in
pancreatic b cells (BESTO mice) show improved glucose toler-
ance and enhanced secretion of insulin in response to IPGTT
(Moynihan et al., 2005). Furthermore, overexpression of Sirt1,
like ghrelin ablation attenuates expression ofUcp2. Subsequent
studies will investigate whether ghrelin regulates b cell function
by repressing Sirt1 expression.
ReducedUcp2 expression is consistent with increased sensi-
tivity of pancreatic b cells to glucose, but this does not explain
the acute inhibition of insulin secretion in ghrelin2/2mice follow-
ing ip ghrelin injection (Figures 3C and 3D). Besides the KATP
channel, inhibition of voltage-dependent tetraethylammonium
(TEA) sensitive K+ currents also depolarizes the b cell and aug-
ments Ca2+ influx and glucose dependent increased insulin se-
cretion (MacDonald et al., 2001). However, the acute inhibitory384effect of ghrelin on insulin secretion is only partially diminished
by TEA (Dezaki et al., 2004), suggesting that enhancement of
TEA-sensitive outward K+ currents cannot completely explain
the acute effects of ghrelin. Although the critical signaling ele-
ment for insulin secretion is depolarization-dependent increase
in intracellular Ca2+, a concomitant outflux of a cation or influx of
an anionmust also occur (Neye et al., 2006). Since insulin secre-
tion and Ca2+ influx is augmented following knockout or com-
plete blockade of voltage-dependent K+ currents, other currents
must provide counterions for Ca2+ influx (Neye et al., 2006). Un-
der conditions where voltage-dependent K+ currents are com-
pletely blocked and cause augmentation of Ca2+ influx into
b cells, the addition of nonspecific inhibitors of anion currents
immediately block Ca2+ influx (Best, 1997; Neye et al., 2006).
Since the immediate action of the anion current inhibitors is sim-
ilar to that observed with ghrelin, we speculate that acute ad-
ministration of ghrelin inhibits insulin release by inhibiting anion
currents, perhaps in combination with enhancing TEA-sensitive
outward K+ currents.
Based on genetic models, we havemade four significant con-
clusions regarding the physiological function of ghrelin. First,
although pharmacologically, ghrelin and leptin have opposite
effects on feeding centers in the hypothalamus, ghrelin unop-
posed by leptin does not explain the hyperphagic phenotype.
Second, unopposed ghrelin is not the cause of increased fat de-
position in the leptin deficient ob/ob mice. Third, ablation of
ghrelin augments glucose dependent insulin secretion from
the pancreatic b cell by reducing Ucp2 expression. Fourth, ab-
lation of ghrelin improves peripheral insulin sensitivity. Collec-
tively, our data are consistent with the notion that ghrelin is
a neuromodulatory sensor that controls whole bodymetabolism
according to nutrient intake and body composition by linking the
GH/IGF-1 axis, with glucose sensing, b cell function and fat
mobilization.
Experimental procedures
Generation of ghrelin(2/2).ob/ob mice
The generation of ghrelin2/2 was described by us previously (Sun et al.,
2003). C57BL/6 ob/+ mice were purchased from The Jackson Laboratory.
To generate ghrelin(2/2).ob/ob, ghrelin2/2mice were bred to ob/+ mice cre-
ating compound heterozygotes, ghrelin(+/2)$ob/OB. In the second cross,
compound heterozygotes were bred to each other, and ghrelin2/2$ob/OB
were identified and mated to produce ghrelin2/2$ob/ob (ghrelin-deficient
ob/ob) mice and ghrelin2/2$OB/OB (ghrelin2/2)mice. In parallel, ghrelin(+/+)$
ob/OBmice were bred to each other to produce ghrelin(+/+)$ob/ob (ob/ob) as
well as ghrelin(+/+).OB/OB (WT) mice. To generate the most reliable data,
only littermate pairs were used. All results are presented asmean6 standard
error (SE). For all measurements, statistical analysis was performed using
ANOVA; p < 0.05 was defined as statistically significant.
Body weight, food intake, and blood glucose
Mice were individually housed and maintained from weaning on regular
chow. Body weights and food intake were measured weekly, and blood glu-
cose was measured biweekly at the same time of the day, from 8–14 weeks
of age. Blood glucose values were determined by One-Touch Ultra glucom-
eter (Lifescan, Milpitas, CA).
Body composition and bone density analysis
Body composition and bone density were analyzed by PIXImus densitometer
(Lunar Corp.). The report includes fat and muscle (lean) contents, bone min-
eral density (BMD) and bone mineral content (BMC). Mice were anesthetized
during the procedure.CELL METABOLISM : MAY 2006
Ghrelin’s role in glucose homeostasisCold exposure and metabolic measurements
To determine thermoregulatory ability, mice were individually caged and
placed in a 4ºC cold room for 90 min. The rectal core body temperature
was measured at 15 min intervals using a Temperature Monitoring System
from Indus Instruments (Houston, TX). Plasma insulin, C-peptide, leptin,
and resistin were analyzed by the Mouse Metabolic Phenotyping Center at
Vanderbilt University Medical Center.
Glucose tolerance test, insulin tolerance test, and low-dose
hyperinsulinemic clamp
An intraperitoneal glucose tolerance test (IP-GTT) was performed on con-
scious mice, following an 18 hr fast, by ip injection of D-glucose (0.625 g/kg
for obese mice and 2.5 g/kg for lean mice). Blood glucose was measured
by tail bleeds at 0, 15, 30, 60, and 120 min, post glucose dose. The insulin
tolerance test (ITT) was done similarly, except the mice were fasted for only
8 hr, and Humulin (Eli Lilly and Company, Indianapolis, IN) was administered
by ip injection. 2U/kg ofHumulinwas used for obesemice, and0.75U/kgwas
used for lean mice. A low-dose hyperinsulinemic clamp was performed, and
calculated as described in our previous publication (Saha et al., 2004).
RNA Isolation and real-time RT-PCR
Mouse pancreases were first soaked in RNAlater (Ambion), subsequently
homogenized in TRIzol (Invitrogen), then extracted using guanidinium thio-
cyanate method, as described (Chomczynski and Sacchi, 1987). RNA was
subsequently treated with DNase I (Ambion). Mouse Ucp2 gene-specific
primers and TaqMan probes were designed with Primer Express 2.0 (Applied
Biosystems) using default settings: forward primer, 50-TCACTGTGCCCTTAC
CATGCT; reverse primer, 50-AGGCATGAACCCCTTGTAGAAG (transversing
an exon boundary); and probe, 50-6FAM-AAGGAGGGACCCCGC-MGB-30.
Assays were mixed at final concentrations of 900 nM primer and 250 nM
probe. Reverse transcriptionwasperformed on 1mgof total RNAwith random
primers, utilizing TaqMan reverse transcription reagents (Applied Biosys-
tems) as recommended by the manufacturer. One tenth of the reverse tran-
scription reaction was used as a template for the subsequent PCR reaction,
whichwas carried out in triplicate. Thermal cyclingwas carried outwith anABI
prism 7000 sequence detection system (Applied Biosystems) under factory
defaults (50ºC, 2 min; 95ºC, 10 min; and 40 cycles at 95ºC, 15 s; 60ºC, 1 min).
Threshold cycle number (Ct) was defined as fluorescence values exceeding
baseline; it was further normalized to the Ct of internal control 18 S ribosomal
RNA, and the relative quantification was calculated using DDCt formula.
Relative Ucp2mRNA expression was shown as fold expression over WT.
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